Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting ... of this stent platform in larger groups of patients. Elixir Medical (CA, USA) reported ...
It also provides the benefits of a drug-eluting stent without the need to implant a permanent scaffold. Concept Medical founder and managing director Dr Manish Doshi said: “The MagicTouch ...
A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...
Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting ... emergency medical attention any time you develop potential side effects of stent thrombosis ...
WASHINGTON--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive ... to contemporary Resolute Onyx ™ zotarolimus drug-eluting stent (DES) for target lesion failure (TLF) in complex patient ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...
Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...
Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or ...
Medpage Today on MSN16d
Stent-Like Hybrid on Track for Lofty Long-Term Goals in PCITCT discussant Joanna Wykrzykowska, MD, PhD, of University Medical Center Groningen in the Netherlands, said she was "very ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback